Apr 7, 2022, 17:59 PM by

Stanley Capital-backed portfolio company DSS acquires MyMeds&Me 04 April 2022, London - Stanley Capital Partners LLP (SCP), the European and US-focused mid-market private equity firm, today announced the acquisition of MyMeds&Me Limited (MMM) by its portfolio company Drug Safety and Pharmacovigilance Services Solutions (DSS). DSS is a leading global provider of pharmacovigilance services under the brand Bioclinica. The financial terms of the transaction are not being disclosed.

Apr 7, 2022, 17:59 PM by

Content 1 Magnus Group is proud and honoured to invite you to its leading congress in catalysis and chemical engineering, “13th Edition of International Conference on Catalysis, Chemical Engineering and Technology” (Catalysis 2022) which is going to be held in a hybrid format at Orlando, Florida, USA and Virtually during October 21-22, 2022.

Apr 7, 2022, 17:59 PM by

New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics

Apr 7, 2022, 17:59 PM by

Apr 7, 2022, 17:59 PM by

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

Apr 7, 2022, 17:59 PM by

VERICHEM now offers clinical laboratorians a comprehensive range of liquid stable and ready-to-use biosynthetic clinical reference materials designed for system calibration and calibration verification testing procedures with urine chemistry assays.

Apr 7, 2022, 17:59 PM by

CluePoints Continues Impressive Global Growth with Three New Senior Appointments The company welcomes new VP Marketing, VP People, and VP Business Operations to its expanding team King of Prussia, PA – 5th April, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations.

Apr 7, 2022, 17:59 PM by

Leading CROs Increase Adoption of WCG's Suite of Solutions Enabling Connectivity to Top Clinical Trial Sites Via Unrivaled Technology and Staffing Solutions Global Program Drives Collaboration to Increase Efficiency and Reduce Burden on Investigative Sites, Accelerating Clinical Trials Sponsored by Pharmaceutical, Biotech and Medical Device Companies

Apr 7, 2022, 17:59 PM by

Seasoned Healthcare Industry Executive Joins Organization to Lead Business Development, Acquisitions, and Expansion into New Markets

Apr 7, 2022, 17:59 PM by

Apr 7, 2022, 17:59 PM by

Apr 7, 2022, 17:59 PM by

Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease.

Apr 7, 2022, 17:59 PM by

Cloud software platform PubHive Navigator saves time for life science teams by expanding journal article access via the platform’s research literature workflow module Fetch

Apr 7, 2022, 17:59 PM by

Earlier this year, Alfa Chemistry, a well-established chemical supplier based in New York, announced its decision to further optimize its supply of MOF chemicals, a new material that has huge potentials in fields like gas storage, separation, and catalysis. Now the company has completed the website refresh work and introduced a new brand logo. All these efforts are made in the hope of bringing better customer experience and more convenient website searching.

Apr 7, 2022, 17:59 PM by

Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.

Apr 7, 2022, 17:59 PM by

Global POC Blood Gas and Electrolyte Market share accounted for up to US$1.95 Bn. It is predicted to reach approximately US$3.6 Bn by 2028, with a steady CAGR of 7.89% throughout the time frame of 2020-2028.

Apr 7, 2022, 17:59 PM by

Apr 7, 2022, 17:59 PM by

Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV).

Apr 7, 2022, 01:00 AM by User Not Found

Bio-IT World | There was no escaping last week’s announcement that the final 8% of the human genome—the equivalent of an entire DNA chromosome—has been sequenced, filling a gap left nearly 20 years after the Human Genome Project declared victory. More than 100 researchers from around the world collaborated on the initiative and many of them, and the institutions they represent, have weighed in on the feat.

Apr 5, 2022, 01:00 AM by User Not Found

Bio-IT World | Penn State researchers have created synthetic “prediction markets” for speculating on the replicability of published studies with unparalleled accuracy. When betting on published social and behavioral science papers, about 90% of the time bot agents correctly “bought” papers that were eventually reproduced.